On the contrary, Mattias Berglund et al. on their study over 168 de novo DLBCL cases found no difference in overall survival between patients with the IL-10-1082AG/GG genotype and patients with the IL-10-1082AA genotype [34,59]. The gene discussed is IL10; the disease is diffuse large B-cell lymphoma.